Bicara Therapeutics BCAX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's accretion (amortization) of discounts and premiums, investments?
- Bicara Therapeutics (BCAX) reported accretion (amortization) of discounts and premiums, investments of -$338K in Q1 2026.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This metric captures the non-cash adjustments to the carrying value of investment securities resulting from the amortization of premiums or the accretion of discounts. It aligns the interest income recognized in the income statement with the effective yield of the investment portfolio. This adjustment is essential for reconciling net income to net cash provided by operating activities.